Jing Lin

Title: Innovations of Jing Lin in Pharmaceutical Formulations

Introduction

Jing Lin is an accomplished inventor based in Mulgrave, Australia. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 5 patents. His work focuses on improving the delivery and efficacy of low solubility active ingredients.

Latest Patents

One of Jing Lin's latest innovations is the development of enteric softgel capsules. These capsules comprise a fill material and an enteric shell composition, characterized by achieving enteric properties without the need for conventional enteric coatings or added polymers. Another notable invention is the self-microemulsifying dosage forms of low solubility active ingredients, such as coenzyme Q10. This invention includes dosage formulations and methods for providing oral dosage forms that enhance the dissolution properties and storage stability of these active ingredients.

Career Highlights

Throughout his career, Jing Lin has worked with reputable companies in the pharmaceutical industry, including R.P. Scherer Technologies, Inc. and Catalent Australia Pty Ltd. His experience in these organizations has allowed him to refine his expertise in drug delivery systems and formulation development.

Collaborations

Jing Lin has collaborated with several professionals in his field, including Hung Truong and Humera Ahmad. These collaborations have contributed to the advancement of his innovative work in pharmaceutical formulations.

Conclusion

Jing Lin's contributions to the field of pharmaceutical innovations demonstrate his commitment to enhancing drug delivery systems. His patents reflect a deep understanding of formulation science and a dedication to improving patient outcomes.